Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

Bespak, Orbia Fluor & Energy Materials collaborate to accelerate transition to climate-friendly inhalers: Holmes Chapel, UK Thursday, November 7, 2024, 18:00 Hrs [IST] Bespak, a s ...

Discover essential tips for managing asthma in children and effectively handling emergencies to keep them safe and healthy.

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), and Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) Fluor & Energy Materials (Koura), a global ...

Asthma Australia and Deakin University introduce a roadmap to enhance asthma care while significantly reducing greenhouse gas emissions from inhalers. The initiative promotes dry powder inhalers as a ...

Wis., has backed efforts to reduce prescription drug prices: Cosponsored 2024 legislation to cap annual out-of-pocket costs at $2,000 per individual and $4,000 per family for people with private ...

That is to say, drug expiration dates aren’t “bad after” dates as much as they are “good before” dates. For most drugs, these dates are set to about three years after the day they’re produced, says ...

Mumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a ...

The Dublin rockers will support their new album with the Open Wide World Tour, which includes their biggest ever headline UK ...